BACKGROUND: Risk factors for type 2 diabetes remain poorly characterized among Aboriginal Canadians. We aimed to determine the incidence of type 2 diabetes in an Aboriginal community and to evaluate prospective associations with metabolic syndrome and its components. METHODS: Of 606 participants in the Sandy Lake Health and Diabetes Project from 1993 to 1995 who were free of diabetes at baseline, 540 (89.1%) participated in 10-year follow-up assessments. Baseline anthropometry, blood pressure, fasting insulin and serum lipid levels were measured. Fasting and 2-hour postload glucose levels were obtained at follow-up to determine incident cases of type 2 diabetes. RESULTS: The 10-year cumulative incidence of diabetes was 17.5%. High adiposity, dyslipidemia, hyperglycemia, hyperinsulinemia and hypertension at baseline were associated with an increased risk of diabetes after adjustment for age and sex (all p < or = 0.03). Metabolic syndrome had high specificity (75%-88%) and high negative predictive value (85%-87%) to correctly detect diabetes-free individuals at follow-up. It had low sensitivity (26%-48%) and low positive predictive value (29%-32%) to detect future diabetes. Metabolic syndrome at baseline was associated with incident diabetes after adjustment for age and sex, regardless of whether the syndrome was defined using the National Cholesterol Education Program criteria (odds ratio [OR] 2.03, 95% confidence interval [CI] 1.10-3.75) or the International Diabetes Federation criteria (OR 2.14, 95% CI 1.29-3.55). The association was to the same degree as that for impaired glucose tolerance assessed using the oral glucose tolerance test (OR 2.87, 95% CI 1.52-5.40; p > 0.05 for comparison of C statistics). INTERPRETATION: Metabolic syndrome and its components can be identified with readily available clinical measures. As such, the syndrome may be useful for identifying individuals at risk of type 2 diabetes in remote Aboriginal communities.
BACKGROUND: Risk factors for type 2 diabetes remain poorly characterized among Aboriginal Canadians. We aimed to determine the incidence of type 2 diabetes in an Aboriginal community and to evaluate prospective associations with metabolic syndrome and its components. METHODS: Of 606 participants in the Sandy Lake Health and Diabetes Project from 1993 to 1995 who were free of diabetes at baseline, 540 (89.1%) participated in 10-year follow-up assessments. Baseline anthropometry, blood pressure, fasting insulin and serum lipid levels were measured. Fasting and 2-hour postload glucose levels were obtained at follow-up to determine incident cases of type 2 diabetes. RESULTS: The 10-year cumulative incidence of diabetes was 17.5%. High adiposity, dyslipidemia, hyperglycemia, hyperinsulinemia and hypertension at baseline were associated with an increased risk of diabetes after adjustment for age and sex (all p < or = 0.03). Metabolic syndrome had high specificity (75%-88%) and high negative predictive value (85%-87%) to correctly detect diabetes-free individuals at follow-up. It had low sensitivity (26%-48%) and low positive predictive value (29%-32%) to detect future diabetes. Metabolic syndrome at baseline was associated with incident diabetes after adjustment for age and sex, regardless of whether the syndrome was defined using the National Cholesterol Education Program criteria (odds ratio [OR] 2.03, 95% confidence interval [CI] 1.10-3.75) or the International Diabetes Federation criteria (OR 2.14, 95% CI 1.29-3.55). The association was to the same degree as that for impaired glucose tolerance assessed using the oral glucose tolerance test (OR 2.87, 95% CI 1.52-5.40; p > 0.05 for comparison of C statistics). INTERPRETATION:Metabolic syndrome and its components can be identified with readily available clinical measures. As such, the syndrome may be useful for identifying individuals at risk of type 2 diabetes in remote Aboriginal communities.
Authors: Juan Liu; T Kue Young; Bernard Zinman; Stewart B Harris; Philip W Connelly; Anthony J G Hanley Journal: Obesity (Silver Spring) Date: 2006-03 Impact factor: 5.002
Authors: William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan Journal: N Engl J Med Date: 2002-02-07 Impact factor: 91.245
Authors: Ojistoh Kahnawahere Horn; Heather Jacobs-Whyte; Amy Ing; Amanda Bruegl; Gilles Paradis; Ann C Macaulay Journal: Can J Public Health Date: 2007 Nov-Dec
Authors: Pirjo Ilanne-Parikka; Johan G Eriksson; Jaana Lindström; Markku Peltonen; Sirkka Aunola; Helena Hämäläinen; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Timo T Valle; Jorma Lahtela; Matti Uusitupa; Jaakko Tuomilehto Journal: Diabetes Care Date: 2008-01-09 Impact factor: 19.112
Authors: Sylvia H Ley; Stewart B Harris; Philip W Connelly; Mary Mamakeesick; Joel Gittelsohn; Thomas M Wolever; Robert A Hegele; Bernard Zinman; Anthony J Hanley Journal: Clin Chem Date: 2010-01-28 Impact factor: 8.327
Authors: Sylvia H Ley; Robert A Hegele; Stewart B Harris; Mary Mamakeesick; Henian Cao; Philip W Connelly; Joel Gittelsohn; Ravi Retnakaran; Bernard Zinman; Anthony J Hanley Journal: BMC Med Genet Date: 2011-01-05 Impact factor: 2.103
Authors: Julia D Rempel; Juliet Packiasamy; Heather J Dean; Jonathon McGavock; Alyssa Janke; Mark Collister; Brandy Wicklow; Elizabeth A C Sellers Journal: Int J Circumpolar Health Date: 2013-08-05 Impact factor: 1.228